Karla Arévalo received her medical degree from the Universidad Nacional Autonoma de Mexico (UNAM) (2016), Mexico and within International Master in Innovative Medicine (IMIM) from the University of Heidelberg, University of Groningen, and Uppsala University, the master degrees in Translational Medicine (2017) and Medical and Pharmaceutical Drug Innovation (2018). In September 2018, Karla started working as a PhD candidate under supervision of prof. Van der Meer and co-supervised by Dr. Martijn Hoes and Dr. Jasper Tromp at the Experimental Cardiology department of the University Medical Center Groningen (UMCG).
Her study will elucidate the differences between diabetic patients with and without heart failure by assessing patient specific mRNA targets and determining the mechanistic implications of identified targets in vitro (stem cell derived cardiomyocytes) and in vivo.
Facilitate personalized therapies in patients with heart failure
Stem cell models to unravel the susceptibility and resilience to develop heart failure